QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR

Yesterday (05/14), I let overconfidence get the best of me on $QNRX. I convinced myself I was in a solid position, even as the price action clearly shifted into a downtrend and my stop-loss was hit. I ignored it. Why? Because the stock had “good news” — positive initial clinical data from its Pediatric Peeling Skin Syndrome study.
Guess what? Bears hate children.
(Okay, jokes aside…)
The market doesn’t care about your news, your bias, or your optimism. Price is king. Always respect your stop-loss, or you’ll end up learning the hard way — like I did. A small planned loss is manageable. An unplanned one can wreck your day or worse.
Stay disciplined out there.

Yesterday (05/14), I let overconfidence get the best of me on $QNRX. I convinced myself I was in a solid position, even as the price action clearly shifted into a downtrend and my stop-loss was hit. I ignored it. Why? Because the stock had “good news” — positive initial clinical data from its Pediatric Peeling Skin Syndrome study.
Guess what? Bears hate children.
(Okay, jokes aside…)
The market doesn’t care about your news, your bias, or your optimism. Price is king. Always respect your stop-loss, or you’ll end up learning the hard way — like I did. A small planned loss is manageable. An unplanned one can wreck your day or worse.
Stay disciplined out there.